Publications in collaboration with researchers from Instituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia (6)

2024

  1. Role of the receptor for advanced glycation end products (RAGE) in blood as a potential biomarker for progression to olaparib: A post hoc analysis of patients with platinum-resistant ovarian cancer (PROC) treated in the ROLANDO-GEICO 1601 trial

    Journal of Clinical Oncology, Vol. 42, Núm. 16

2020

  1. Clinical relevance of +936 c>t vegfa and c.233c>t bfgf polymorphisms in chronic lymphocytic leukemia

    Genes, Vol. 11, Núm. 6, pp. 1-13

2019

  1. A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients

    Clinical Epigenetics, Vol. 11, Núm. 1

2017

  1. The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene

    Scientific Reports, Vol. 7

2016

  1. The antitumor effect of metformin is mediated by miR-26a in breast cancer

    International Journal of Molecular Sciences, Vol. 17, Núm. 8

2015

  1. MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer

    Journal of Cellular Biochemistry, Vol. 116, Núm. 9, pp. 2061-2073